148 related articles for article (PubMed ID: 28057908)
1. Clinical application of quantitative computed tomography in osteogenesis imperfecta-suspected cat.
Won S; Chung WJ; Yoon J
J Vet Sci; 2017 Sep; 18(3):415-417. PubMed ID: 28057908
[TBL] [Abstract][Full Text] [Related]
2. Suspect osteogenesis imperfecta in a male kitten.
Evason MD; Taylor SM; Bebchuk TN
Can Vet J; 2007 Mar; 48(3):296-8. PubMed ID: 17436908
[TBL] [Abstract][Full Text] [Related]
3. [Influence of bisphosphonate treatment on the radiological features of osteogenesis imperfecta in children].
Chigladze TT; Zhvaniia MA; Bekua MV
Georgian Med News; 2006 Feb; (131):62-5. PubMed ID: 16575136
[TBL] [Abstract][Full Text] [Related]
4. Osteogenesis Imperfecta: Skeletal Outcomes After Bisphosphonate Discontinuation at Final Height.
Robinson ME; Trejo P; Palomo T; Glorieux FH; Rauch F
J Bone Miner Res; 2019 Dec; 34(12):2198-2204. PubMed ID: 31356699
[TBL] [Abstract][Full Text] [Related]
5. Experience with bisphosphonates in osteogenesis imperfecta.
Glorieux FH
Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta.
Shapiro JR; Thompson CB; Wu Y; Nunes M; Gillen C
Calcif Tissue Int; 2010 Aug; 87(2):120-9. PubMed ID: 20544187
[TBL] [Abstract][Full Text] [Related]
7. Effect of denosumab on the growing skeleton in osteogenesis imperfecta.
Hoyer-Kuhn H; Semler O; Schoenau E
J Clin Endocrinol Metab; 2014 Nov; 99(11):3954-5. PubMed ID: 25148238
[No Abstract] [Full Text] [Related]
8. Effect of intravenous pamidronate treatment in children with osteogenesis imperfecta.
Atta I; Iqbal F; Lone SW; Ibrahim M; Khan YN; Raza J
J Coll Physicians Surg Pak; 2014 Sep; 24(9):653-7. PubMed ID: 25233970
[TBL] [Abstract][Full Text] [Related]
9. Fracture during intravenous bisphosphonate treatment in a child with osteogenesis imperfecta: an argument for a more frequent, low-dose treatment regimen.
Biggin A; Briody JN; Ormshaw E; Wong KK; Bennetts BH; Munns CF
Horm Res Paediatr; 2014; 81(3):204-10. PubMed ID: 24356182
[TBL] [Abstract][Full Text] [Related]
10. Zolendronate in osteogenesis imperfecta.
Panigrahi I; Das RR; Marwaha RK
J Pediatr Endocrinol Metab; 2009 Aug; 22(8):763. PubMed ID: 19845128
[No Abstract] [Full Text] [Related]
11. Successful results of pamidronate treatment in children with osteogenesis imperfecta with emphasis on the interpretation of bone mineral density for local standards.
Poyrazoglu S; Gunoz H; Darendeliler F; Bas F; Tutunculer F; Eryilmaz SK; Bundak R; Saka N
J Pediatr Orthop; 2008 Jun; 28(4):483-7. PubMed ID: 18520289
[TBL] [Abstract][Full Text] [Related]
12. Fractures on bisphosphonates in osteoporosis pseudoglioma syndrome (OPPG): pQCT shows poor bone density and structure.
Streeten EA; Ramirez S; Eliades M; Jaimungal S; Chandrasekaran S; Kathleen R; Holmes Morton D; Puffenberger EG; Herskovitz R; Leonard MB
Bone; 2015 Aug; 77():17-23. PubMed ID: 25892485
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive evaluation of bone health using DXA and pQCT in an Indian boy with osteogenesis imperfecta.
Karguppikar MB; Ekbote V; Khadilkar A; Khadilkar V
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318265
[TBL] [Abstract][Full Text] [Related]
14. Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta.
Aström E; Jorulf H; Söderhäll S
Arch Dis Child; 2007 Apr; 92(4):332-8. PubMed ID: 17114205
[TBL] [Abstract][Full Text] [Related]
15. Oral bisphosphonate treatment for osteogenesis imperfecta--an Indian perspective.
Shah I; Johari A
Ann Trop Paediatr; 2007 Mar; 27(1):39-43. PubMed ID: 17469731
[TBL] [Abstract][Full Text] [Related]
16. Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation.
Rauch F; Munns C; Land C; Glorieux FH
J Clin Endocrinol Metab; 2006 Apr; 91(4):1268-74. PubMed ID: 16434452
[TBL] [Abstract][Full Text] [Related]
17. Growth of infants with osteogenesis imperfecta treated with bisphosphonate.
Hasegawa K; Inoue M; Seino Y; Morishima T; Tanaka H
Pediatr Int; 2009 Feb; 51(1):54-8. PubMed ID: 19371278
[TBL] [Abstract][Full Text] [Related]
18. Bone fragility in a kitten: an osteogenesis imperfecta-like syndrome.
Cohn LA; Meuten DJ
J Am Vet Med Assoc; 1990 Jul; 197(1):98-100. PubMed ID: 2370230
[TBL] [Abstract][Full Text] [Related]
19. Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?
Ward KA; Adams JE; Freemont TJ; Mughal MZ
Osteoporos Int; 2007 Aug; 18(8):1137-40. PubMed ID: 17279467
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of osteogenesis imperfecta with bisphosphonates].
Tau C
Medicina (B Aires); 2007; 67(4):389-95. PubMed ID: 17891938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
